Detalhe da pesquisa
1.
Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial.
Front Neurol
; 15: 1303402, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638315
2.
BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba.
J Interferon Cytokine Res
; 43(12): 571-580, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048299
3.
Correction to "Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study" [The Lancet Regional Health - Americas 2022; 16: 100366] https://doi.org/10.1016/j.lana.2022.100366.
Lancet Reg Health Am
; 18: 100422, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593764
4.
Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study).
EClinicalMedicine
; 63: 102160, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649806
5.
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study).
Lancet Reg Health Am
; 21: 100497, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192953
6.
Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study.
Lancet Reg Health Am
; 16: 100366, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36185968
7.
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study).
EClinicalMedicine
; 46: 101383, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35434578
8.
Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.
Hum Vaccin
; 4(1): 54-9, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18441530
9.
Correlación fisiopatológica, diagnóstica y terapéutica en el derrame pleural paraneumónico / Pathophysiological, diagnostic and therapeutic correlation in parapneumonic pleural effusion
Rev. cuba. pediatr
; 952023. ilus, tab
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1515282
10.
Ensayo controlado y aleatorizado del uso de Heberkinasa® en el derrame pleural paraneumónico en niños / Randomized Controlled Trial of the Use of Heberkinase® in Parapneumonic Pleural Effusion in Children
Rev. cuba. pediatr
; 952023. ilus, tab
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1515290
11.
Administración intrapleural de estreptoquinasa recombinante en tres niños graves con derrame pleural paraneumónico complicado / Intrapleural administration of recombinant streptokinase in three seriously ill children with complicated parapneumonic pleural effusion
Rev. cuba. pediatr
; 93(2): e1148, graf
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1280374
12.
Registro sanitario de Heberprot-P®, medicamento biotecnológico innovador para el tratamiento de las úlceras del pie diabético / Sanitary registration of Heberprot-P®, an innovative biotechnological drug for the treatment of diabetic foot ulcers
Rev. cuba. salud pública
; 47(4)dic. 2021.
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1409254
13.
Eficacia y seguridad de la estreptoquinasa recombinante en niños con derrame pleural paraneumónico / Effectiveness and security of recombinant streptokinase in children with parapneumonic pleural efussion
Rev. cuba. pediatr
; 92(3): e1092, jul.-set. 2020. tab, graf
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1126767
14.
Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults.
Biologicals
; 35(2): 115-22, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17056272